Limited clinical utility of blood and urine cultures in the treatment of acute pyelonephritis during pregnancy

American Journal of Obstetrics and Gynecology

Volumn 182, Issue 6, 2000, Pages 1437-1441

  Wing, Deborah A ^a   Park, Alane S ^a   DeBuque, Laurie ^b   Millar, Lynnae K ^b  

^a WOMEN S AND CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

Blood culture; Pregnancy; Pyelonephritis; Urine culture

Indexed keywords

AMPICILLIN; CEPHALOSPORIN DERIVATIVE; GENTAMICIN;

ACUTE PYELONEPHRITIS; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATION; BLOOD CULTURE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URINE CULTURE;

EID: 0033946383     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2000.106135     Document Type: Article

References (18)

1. 1. Gilstrap LC 3d, Cunningham FG, Whalley PJ. Acute pyelonephritis in pregnancy: an anterospective study. Obstet Gynecol 1981;57:409-13.
2. 2. MacMillan MC, Grimes DA. The limited usefulness of urine and blood cultures in treating pyelonephritis in pregnancy. Obstet Gynecol 1991;78:745-8.
3. 3. McMurray BR, Wrenn KD, Wright SW. Usefulness of blood cultures in pyelonephritis. Am J Emerg Med 1997;15:137-40.
4. 4. Thanassi M. Utility of urine and blood cultures in pyelonephritis. Acad Emerg Med 1997;4:797-800.
5. 5. Millar LK, Wing DA, Paul RH, Grimes DA. Outpatient treatment of pyelonephritis in pregnancy: a randomized controlled trial. Obstet Gynecol 1995;86:560-4.
6. 6. Wing DA, Hendershott CM, Debuque L, Millar LK. A randomized trial of three antibiotic regimens for the treatment of pyelonephritis in pregnancy. Obstet Gynecol 1998;92:249-53.
7. 6a. Wing DA, Hendershott CM, Debuque L, Millar LK. Outpatient treatment of pyelonephritis in pregnancy at greater than 24 weeks estimated gestational age. Obstet Gynecol 1999;93:683-8.
8. 7. Van Dorsten JP, Lenke RR, Schifrin BS. Pyelonephritis in pregnancy: the role of in-hospital management and nitrofurantoin suppression. J Reprod Med 1987;32:895-900.
9. 8. 1998 drug topics red book. 102nd ed. Montvale (NJ): Medical Economics; 1998.
10. 9. Healthcare Consultants of America. 1997 physician's fee and coding guide: a comprehensive fee and coding reference. Augusta (GA): Healthcare Consultants of America; 1997.
11. 10. Bates DW, Cook EF, Goldman L. Predicting bacteremia in hospitalized patients: a prospectively validated model. Ann Intern Med 1990;113:495-500.
12. 11. Arbo MD, Syndmann DR. Influence of blood culture results on antibiotic choice in the treatment of bacteremia. Arch Intern Med 1994;154:2641-5.
13. 12. Fan YD, Pastorek JG 2d, Miller JM Jr, Mulvey J. Acute pyelonephritis in pregnancy. Am J Perinatol 1987;4:324-6.
14. 13. Lietman PS, Smith CR. Aminoglycoside nephrotoxicity in humans. Rev Infect Dis 1983;5:S284-93.
15. 14. Whalley PJ, Cunningham FG, Martin FG. Transient renal dysfunction associated with acute pyelonephritis of pregnancy. Obstet Gynecol 1975;46:174-7.
16. 15. Hyams KC. Inappropriate urine cultures in hospitalized patients receiving antibiotic therapy. Arch Intern Med 1987;147:48-9.
17. 16. Lenke RR, VanDorsten JP, Schifrin BS. Pyelonephritis in pregnancy: a prospective randomized trial to prevent recurrent disease evaluating suppressive therapy with nitrofurantoin and close surveillance. Am J Obstet Gynecol 1983;146:953-7.
18. 17. Sandberg T, Brorson JE. Efficacy of long-term antimicrobial prophylaxis after acute pyelonephritis in pregnancy. Scand J Infect Dis 1991;23:221-3.